Secondary analysis of the HEAL trial (180 infants with moderate-severe HIE): day-2 blood Tau predicted cerebral palsy at 2 years (AUC 0.902; sensitivity 88%, specificity 91%), similar to MRI scoring, but predicted cognitive/language delay less well (AUC 0.669).
Secondary analysisn = 180
Clifford et al. Blood-Based Biomarkers Predict Cerebral Palsy and Cognitive Delay in Hypoxic-Ischemic Encephalopathy: A Secondary Analysis of the High-Dose Erythropoietin for Asphyxia and Encephalopathy Randomized Controlled Trial